ClinicalTrials.Veeva

Menu

Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and Schizophrenia (PathRisk)

U

University of Konstanz

Status

Unknown

Conditions

Alcohol Use Disorder (AUD)
Schizophrenia and Related Disorders

Treatments

Behavioral: Cognitive Behavioral Therapy for increasing non-risk behaviors
Behavioral: Cognitive Behavioral Therapy for reducing risk behaviors

Study type

Interventional

Funder types

Other

Identifiers

NCT04985786
OD 113/3-1

Details and patient eligibility

About

The hyper- or hypo-attribution of risks is deeply related to the core pathological mechanisms of mental disorders and at the same time engaging in risky behaviors influences their course and outcomes. The investigators study risk perception, risk behaviors and underlying brain mechanisms in a longitudinal design in three groups of psychiatric patients who participate in a psychological intervention that is aimed to reduce risk behavior and increase risk perception.

Patients with schizophrenia (SZ), alcohol use disorder (AUD) and both disorders (SZ + AUD) are recruited during psychiatric in-patient treatment and participate in a combined face-to-face and mobile intervention that starts before release and ends four weeks after discharge. The standardized 4-session face-to-face group intervention that is based on motivational interviewing (Miller & Rollnick, 2013) and relapse prevention (Marlatt & Donovan, 2005) and addresses the reduction of disorder-specific risk behaviors, i.e. alcohol use for AUD and SZ+AUD and medication non-adherence for SZ. After discharge, a 4-week ecological momentary intervention (EMI) supports participants to maintain abstinence from risk behaviors and to strengthen coping in high-risk situations relying on mental contrasting and implementation intentions (Oettingen & Gollwitzer, 2011). Participants will be assessed in fMRI and behavioral measurements and by self-report pre and post interventional phase, furthermore they participate in an ecological momentary assessment during the post-discharge phase which assesses risk behaviors, high-risk situations and risk perception in real life contexts.

Enrollment

240 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • for patient groups: fulfilling the diagnostic criteria for AUD or SZ or both

Exclusion criteria

for patient groups and healthy control group:

  • no sufficient command of German language
  • neurological disorder for patient groups:
  • acute psychotic episode
  • acute suicidality or not distanced from self-harming behaviors
  • other substance use disorder (exception: nicotine and caffeine use disorders) for healthy control group:
  • absence of any psychiatric diagnosis (exception: nicotine and caffeine use disorders)

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

240 participants in 7 patient groups

AUD Intervention
Experimental group
Description:
Risk behavior specific intervention, targeting alcohol drinking
Treatment:
Behavioral: Cognitive Behavioral Therapy for reducing risk behaviors
AUD Control
Active Comparator group
Description:
Non-risk behavior specific intervention, targeting cognitive exercises
Treatment:
Behavioral: Cognitive Behavioral Therapy for increasing non-risk behaviors
AUD & SZ Intervention
Experimental group
Description:
Risk behavior specific intervention, targeting alcohol drinking
Treatment:
Behavioral: Cognitive Behavioral Therapy for reducing risk behaviors
AUD & SZ Control
Active Comparator group
Description:
Non-risk behavior specific intervention, targeting cognitive exercises
Treatment:
Behavioral: Cognitive Behavioral Therapy for increasing non-risk behaviors
SZ Intervention
Experimental group
Description:
Risk behavior specific intervention, targeting medication non-adherence
Treatment:
Behavioral: Cognitive Behavioral Therapy for reducing risk behaviors
SZ Control
Active Comparator group
Description:
Non-risk behavior specific intervention, targeting cognitive exercises
Treatment:
Behavioral: Cognitive Behavioral Therapy for increasing non-risk behaviors
HC Control
No Intervention group
Description:
Healthy control subjects will participate in fMRI assessments only

Trial contacts and locations

1

Loading...

Central trial contact

Michael Odenwald, Dr.; Daniela Mier, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems